A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

CompletedOBSERVATIONAL
Enrollment

1,349

Participants

Timeline

Start Date

January 19, 2016

Primary Completion Date

November 12, 2021

Study Completion Date

November 12, 2021

Conditions
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Trial Locations (21)

10016

New York University Hospital, New York

10027

Columbia University, New York

43210

The Ohio State University, Columbus

60637

University of Chicago Medical Center, Chicago

84112

University of Utah, Salt Lake City

94305

Stanford Gastroenterology and Hepatology, Stanford

97239

Oregon Health & Science University, Portland

06520-8327

Yale University, New Haven

02114

Massachusetts General Hospital, Boston

01655

University of Massachusetts, Worcester

10029-6574

Mount Sinai Hospital, New York

19104-6061

University of Pennsylvania, Philadelphia

15213-2582

University of Pittsburgh Medical Center, Pittsburgh

Unknown

The Research Institute of the McGill University Health Centre, Montreal

University Hospital Ramon y Cajal, Madrid

University Hospital Santiago De Compostela, Santiago de Compostela

Sahlgrenska University Hospital, Gothenburg

Linköping University Hospital, Linköping

Karolinska University Hospital, Stockholm

Umeå University Hospital, Umeå

University Collage London Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Immunovia, Inc.

INDUSTRY